![[Coumadin Logo]](http://www.oralchelation.com/images/coumlogo.gif)
Click here to return to the FAQ about Coumadin
The main page includes this:
Dear Karl,
My wife and been taking Warfarin [Coumadin] for about 1 year and went to a Coumadin Club.
On a Friday she went to a DR. because she was felling light headed.
The doctor said she had Labyrinthitis and gave her Antivert.
Four days later we had dinner and the next day I went to work to come home and found her past away.
She was 60 years old. Have you heard of any drug interaction of this kind.
Or send me a Webb site for more info.
I asked for a autopsy and it has been 8 weeks and no result.
Thank you for your time.
Here is information of interest.
Antivert is an antihistamine sometimes used to control vertigo associated with MS.
Coumadin is a blood thinner, also called Warfarin. Coumadin is a rat poison.
GENERIC NAME: Meclizine hydrochloride [ Mek-li-zeen]
TYPE OF MEDICATION USE
: Prevention and treatment of symptoms of motion sicknessManagement of vertigo with diseases affecting the vestibular system
PHARMACY FACTS
: Metabolized in the kidney and unchanged and unmetabolized and excreted in thefeces
CONTRAINDICATIONS
: Hypersensitivity to Antivert and contraindicated in pregnancyUSE CAUTIOUSLY IN THE FOLLOWING DISORDERS:
Narrow-angle glaucoma, prostatic hypertrophy,pyloric or duodenal obstruction, bladder neck obstruction
Use cautiously in the elderly who may be at risk for anticholinergic effects such as glaucoma,
prostatic hypertrophy, constipation, and intestinal obstruction
Use with caution in hot weather and during exercise
SIDE EFFECTS:
Neurological: Drowsiness, headache, fatigue, nervousness, dizziness, and arthralgia
ENT: Pharyngitis
Respiratory: Thickening of bronchial secretions
Gastro: Appetite increase, weight gain, nausea, diarrhea, abdominal pain, xerostomia
GU: Urinary retention
DRUG INTERACTIONS:
Increased toxicity with CNS depressants, neuroleptics and anticholinergicsDOSAGE:
For greater than 12 years of age: 12.5 to 25 mg one hour before traveling, repeating doseevery 12 to 24 hours if needed
Doses up to 50 mg may be needed for motion sickness
For vertigo, 25-100 mg per day in divided doses
SPECIAL ADMINISTRATION INSTRUCTIONS:
Avoid alcohol which may have an additive CNS effectPREGNANCY CATEGORY
: BMOST ECONOMICAL
: Comparable to other older first generation antihistaminesNOTES
: NoneeMedicine Journal, July 7 2001, Volume 2, Number 7
Background: Labyrinthitis is an inflammation or dysfunction of the vestibular labyrinth, which is a system of intercommunicating cavities and canals in the inner ear. The syndrome is defined by the acute onset of vertigo that commonly is associated with head or body movement. Nausea, vomiting, or malaise often accompanies the vertigo.
Vertigo is the subjective sensation of environmental movement that may be experienced as a mild subjective instability of the surroundings or, in its most severe form, as a spinning sensation. Vertigo may be experienced and described anywhere between these 2 extremes. Vertigo syndromes have many synonyms, including labyrinthitis, benign positional vertigo, cupulolithiasis, and vestibular neuronitis.
Pathophysiology: The pathophysiology of this syndrome is not completely understood. However, a dysfunction of the vestibular apparatus clearly is present when labyrinthitis occurs.
Theories involve lesions in the otolith organs, degeneration of the utricular macula, or lesions in the posterior semicircular canal. The cupulolithiasis theory suggests that otoconia, which are formed by a dysfunctional utricular macula, settle on the cupula of the posterior semicircular canal, causing aberrant stimulation of the vestibular system.
A more popular theory is that of canalithiasis, as well outlined by Hall in 1979. This theory postulates that free-floating otoconial debris produces pressure in the semicircular canal, causing deflection of the cupula. This deflection results in a transient attack of vertigo.
Many cases of labyrinthitis are associated with systemic or viral-like illnesses. Suppurative or bacterial labyrinthitis is rare, but it should be considered in patients with acute or chronic otitis media. Cases are reported in association with meningitis, but the presentation of the meningitis often overwhelms the vestibular symptoms.
Frequency:
Idiopathic - 49% (118 patients)
Posttraumatic - 18% (43 patients)
Viral neurolabyrinthitis -15% (37 patients)
Miscellaneous - 18% (42 patients)
The miscellaneous etiologies in this study included vertebrobasilar ischemia, Ménière disease, postsurgical ototoxicity, luetic labyrinthitis, and chronic otomastoiditis.
Other studies have shown a lower frequency of idiopathic cases. A specific diagnosis is usually possible in cases of recurrent acute and chronic vertigo. Benign paroxysmal vertigo and Ménière disease are the most frequent causes of peripheral vertigo.
Mortality/Morbidity:
Sex: Combined data from various studies reflect that females with labyrinthitis outnumber males with labyrinthitis (female-to-male ratio 1.5-2:1).
Age: Labyrinthitis can be observed in a patient of any age; however, a significant increase in frequency occurs in the fourth decade of life.
History: Although the vast majority of cases of labyrinthitis are self-limited, a minority of patients can have a more chronic and prolonged course. Patients express difficulties involving vertigo and hearing.
Physical: The importance of a neurological examination cannot be overemphasized.
Causes: Physiologically, a mismatch of vestibular, visual, and somatosensory systems is present. This mismatch is triggered by an external stimulus, such as a stop after turning, a change in altitude, or motion/height sickness. A lesion within vestibular pathways (ie, inner ear to cerebral cortex) causes this imbalance.
|
I promise to answer your message -- click here to send me a personal message
|
SUBSCRIBE: The Wednesday Letter is a free electronic monthly newsletter written and published by Karl Loren. You can view more than 50 back issues of this publication by clicking here. The Wednesday Letter subscription list is maintained on a secure server, no name is ever given or sold to anyone, and it is never used except for this Newsletter. It is automatically published on the Tuesday night just before the first Wednesday of every month. You can subscribe to this free monthly electronic letter by entering your eMail address and name below. You will then automatically receive a request for confirmation, sent to whatever address you have entered. If you do NOT receive this confirmation request, then you will not be subscribed. There may have been an error with your address and you should resubmit. The letter is never sent twice to the same address -- so you do not have to worry about a duplicate subscription. When you receive this confirmation request you must reply to it, or your subscription will not become active. No one can subscribe your name, and address, without you being notified, and if you get an unwanted notice of subscription you only need to DO NOTHING and the subscription will NOT be active.
REMOVAL: You can remove yourself from the subscription list in several different ways. Click here to read about this entire newsletter system. Every edition of The Wednesday Letter is delivered to your address with YOUR name and address in view on the letter, with a link that allows you to remove THAT name from the subscription list. If you try to send this removal message from an address different from the one you used to send in your original confirmation, then you will get a warning notice first, sent to the subscription address, asking you to confirm that you want to be removed from the list -- by replying to THAT request for confirmation, you will then be automatically removed. Thus, no one else can unsubscribe you, from some other computer, without your knowledge. But, if you send in the unsubscribe notice from the same machine used to receive the Letter, then the removal from the subscription list is automatic.
Personal Message: When you send a personal message to Karl Loren, you will receive a personal reply as per his instructions. Karl pledges that every personal message will get a personal answer. When you provide your mail address, we will send you free information including our free catalog and a cassette tape lecture by Karl Loren about heart disease, no charge, by mail, even if outside the US. You can select particular information you would like to receive, along with the free cassette tape and catalog.
You can reach Vibrant Life in many ways, including by mail to Vibrant Life, 2808 N. Naomi St., Burbank, CA 91504. Within the US and Canada, use the toll free number: (800) 523-4521, the local number: (818) 558-1799, the FAX: (818) 558-7299, eMail to kimberly@oralchelation.com or any one of the hundreds of message forms throughout the 50 web sites. Vibrant Life normally ships the same day we get an order. There are message forms on each of the 100,000+ pages on this and other sites where you can communicate with Vibrant Life. Check out our companion site, at: http://www.oralchelation.net where Karl's 2000 page book is published. Karl Loren is the author and webmaster for this BOOK, as well as for another web site about ORAL CHELATION. His personal philosophical articles are at PHILOSOPHY.
Copyright © May 20, 2008 6:23 AM by Karl Loren on behalf of Vibrant Life, ALL RIGHTS RESERVED. Permission is granted for non-commercial downloading, copying, distribution or redistribution on two conditions: One, that some form of copyright notice is included in every copy distributed or copied, showing the copyright belonging to Vibrant Life, Burbank, CA, at www.oralchelation.com . The second condition is that the material is not to be used for any purpose contrary to the purposes and objectives of this site. This permission does not extend to materials on this site which are copyrighted by others.